Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
FREMONT, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences,” “Cytek,” or the “Company”) (Nasdaq:…
4,735$
2,49%
Echtzeit-Aktienkurs Cytek Biosciences
Bid:
Ask:
Nachrichten zur Cytek Biosciences Aktie
Cytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call Transcript
…
Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for
Cytek Biosciences (CTKB) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -50.00% and +0.59%, respectively, for the quarter ended March 2026. Do…
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -166.67% and +0.23%, respectively, for the quarter ended December 2025. Do…
Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
…
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -200.00% and +1.70%, respectively, for the quarter ended September 2025. Do…
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
FREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today…
Cytek Biosciences, Inc. (CTKB) Beats Q2 Earnings Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of +150.00% and -3.30%, respectively, for the quarter ended June 2025. Do…
Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript
…
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -125% and 5.07%, respectively, for the quarter ended March 2025. Do…
Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?
…
Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of 16.67% and 9.49%, respectively, for the quarter ended December 2024. Do…
Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
FREMONT, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today…
Cytek Biosciences stock jumps on new $50M buyback plan By Investing.com
Cytek Biosciences stock jumps on new $50M buyback plan…
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions…
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual BioTech Breakthrough Awards program.…
Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript
…
Cytek Biosciences Reports Third Quarter 2024 Financial Results
FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a…
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
Cytek announced that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification.…
Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript
…
Cytek Biosciences Announces $50 Million Stock Repurchase Program
FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions…
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Cytek has announced its Enhanced Small Particle Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.…
Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript
…
Cytek Biosciences Reports First Quarter 2024 Financial Results
FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a…
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
Cytek® Biosciences will spotlight its cell analysis solutions and conduct educational workshops/tutorials at CYTO and AAIs IMMUNOLOGY2024…
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
FREMONT, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions…
Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader
…
Cytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcript
…
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a…